osa

Latest news and analysis on osa

Equities

The MedTech minnow that could be the next ResMed

Don't sleep on this alternative treatment to CPAP in the massive and growing obstructive sleep apnea market
RMD
+2
Jacob Celermajer
Cordis Asset Management
Equities

Why this ASX medtech stock is dominating the competition

How ResMed is steadily becoming a more dominant player in the global OSA duopoly
RMD
Jacob Celermajer
Cordis Asset Management
2
Elf Footer